EWM
ABBV icon

Endowment Wealth Management’s AbbVie ABBV Stock Holding History

Endowment Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$719K Sell
3,308
-41
-1% -$9.1K 0.32% 62
2025
Q4 		$765K Sell
3,349
-91
-3% -$20.7K 0.35% 59
2025
Q3 		$796K Buy
3,440
+1,016
+42% +$207K 0.36% 60
2025
Q2 		$450K Sell
2,424
-82
-3% -$15.2K 0.23% 80
2025
Q1 		$525K Buy
2,506
+218
+10% +$42.4K 0.34% 65
2024
Q4 		$407K Sell
2,288
-15
-0.7% -$2.76K 0.27% 73
2024
Q3 		$455K Buy
2,303
+87
+4% +$16.2K 0.3% 69
2024
Q2 		$380K Buy
2,216
+15
+0.7% +$2.48K 0.28% 74
2024
Q1 		$401K Sell
2,201
-100
-4% -$17.2K 0.3% 73
2023
Q4 		$357K Sell
2,301
-326
-12% -$47.5K 0.3% 74
2023
Q3 		$392K Buy
2,627
+394
+18% +$57.8K 0.35% 73
2023
Q2 		$301K Sell
2,233
-1
-0% -$147 0.28% 96
2023
Q1 		$356K Sell
2,234
-374
-14% -$57.2K 0.36% 71
2022
Q4 		$422K Buy
2,608
+35
+1% +$5.37K 0.46% 57
2022
Q3 		$345K Buy
2,573
+24
+0.9% +$3.44K 0.42% 67
2022
Q2 		$390K Sell
2,549
-56
-2% -$8.56K 0.47% 59
2022
Q1 		$422K Sell
2,605
-409
-14% -$59.4K 0.44% 56
2021
Q4 		$408K Buy
+3,014
New +$356K 0.41% 50

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Endowment Wealth Management's ABBV Position: Q1 2026 in Review

Endowment Wealth Management reduced its AbbVie (ABBV) stake by 1.2% in Q1 2026, selling an estimated $9.1K and leaving 3,308 shares worth $719K. The position accounts for 0.32% of the portfolio, ranked #62.

Endowment Wealth Management first reported a position in ABBV in Q4 2021 and has held it in 18 quarters since. The position peaked at $796K in Q3 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Endowment Wealth Management held 3,308 shares of AbbVie worth $719K as of Q1 2026.
  • Endowment Wealth Management sold 41 AbbVie shares in Q1 2026, an estimated $9.1K.
  • AbbVie made up 0.32% of Endowment Wealth Management's portfolio in Q1 2026, its #62 holding.
  • Endowment Wealth Management first reported a position in AbbVie in Q4 2021 and has held it in 18 quarters since.
  • Endowment Wealth Management's AbbVie position peaked at $796K in Q3 2025.
  • 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Endowment Wealth Management's 13F filing for Q1 2026, filed 8 May 2026.